Securian Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.37M Sell
65,631
-1,702
-3% -$199K 0.3% 49
2026
Q1
$8.1M Sell
67,333
-158
-0.2% -$18.2K 0.32% 47
2025
Q4
$7.1M Sell
67,491
-53,138
-44% -$4.99M 0.27% 54
2025
Q3
$10.1M Sell
120,629
-10,654
-8% -$878K 0.27% 56
2025
Q2
$10.4M Sell
131,283
-2,679
-2% -$213K 0.3% 58
2025
Q1
$12M Sell
133,962
-1,994
-1% -$186K 0.37% 46
2024
Q4
$13.5M Sell
135,956
-4,240
-3% -$437K 0.39% 39
2024
Q3
$15.9M Sell
140,196
-5,442
-4% -$647K 0.46% 34
2024
Q2
$18M Sell
145,638
-3,614
-2% -$466K 0.53% 30
2024
Q1
$19.7M Sell
149,252
-11,236
-7% -$1.38M 0.58% 27
2023
Q4
$17.5M Sell
160,488
-21,609
-12% -$2.24M 0.5% 30
2023
Q3
$18.7M Sell
182,097
-30,911
-15% -$3.33M 0.56% 30
2023
Q2
$24.6M Sell
213,008
-2,219
-1% -$252K 0.63% 28
2023
Q1
$22.9M Buy
215,227
+889
+0.4% +$96K 0.61% 29
2022
Q4
$23.8M Buy
214,338
+7,901
+4% +$808K 0.67% 28
2022
Q3
$17.8M Buy
206,437
+1,400
+0.7% +$125K 0.53% 32
2022
Q2
$18.7M Sell
205,037
-902
-0.4% -$80K 0.45% 46
2022
Q1
$16.9M Sell
205,939
-2,799
-1% -$221K 0.33% 66
2021
Q4
$16M Sell
208,738
-6,400
-3% -$510K 0.3% 81
2021
Q3
$16.2M Sell
215,138
-2,414
-1% -$184K 0.33% 72
2021
Q2
$16.9M Sell
217,552
-11,570
-5% -$861K 0.34% 66
2021
Q1
$16.9M Sell
229,122
-7,594
-3% -$560K 0.37% 57
2020
Q4
$18.5M Sell
236,716
-7,040
-3% -$538K 0.42% 44
2020
Q3
$19.3M Sell
243,756
-2,673
-1% -$209K 0.47% 39
2020
Q2
$18.2M Sell
246,429
-17,834
-7% -$1.34M 0.47% 42
2020
Q1
$19.4M Sell
264,263
-4,568
-2% -$359K 0.55% 33
2019
Q4
$23.3M Sell
268,831
-11,657
-4% -$957K 0.51% 39
2019
Q3
$22.5M Sell
280,488
-3,843
-1% -$308K 0.52% 42
2019
Q2
$22.7M Buy
284,331
+1,553
+0.5% +$119K 0.53% 44
2019
Q1
$22.4M Sell
282,778
-75
-0% -$5.61K 0.54% 41
2018
Q4
$20.6M Sell
282,853
-862
-0.3% -$60.9K 0.55% 39
2018
Q3
$19.2M Sell
283,715
-3,178
-1% -$202K 0.46% 52
2018
Q2
$16.6M Buy
286,893
+561
+0.2% +$31.6K 0.41% 59
2018
Q1
$14.9M Sell
286,332
-4,646
-2% -$251K 0.38% 65
2017
Q4
$15.6M Buy
290,978
+648
+0.2% +$35.9K 0.39% 65
2017
Q3
$17.7M Buy
290,330
+1,056
+0.4% +$64K 0.46% 56
2017
Q2
$17.7M Sell
289,274
-331
-0.1% -$20.1K 0.47% 54
2017
Q1
$17.6M Sell
289,605
-208
-0.1% -$12.6K 0.47% 53
2016
Q4
$16.3M Buy
289,813
+5,118
+2% +$300K 0.44% 61
2016
Q3
$17M Buy
284,695
+2,413
+0.9% +$141K 0.46% 55
2016
Q2
$15.5M Buy
282,282
+1,869
+0.7% +$99.5K 0.43% 54
2016
Q1
$14.2M Buy
280,413
+469
+0.2% +$23K 0.41% 62
2015
Q4
$14.1M Buy
279,944
+2,729
+1% +$138K 0.42% 58
2015
Q3
$13.1M Sell
277,215
-3,106
-1% -$165K 0.43% 54
2015
Q2
$15.2M Buy
280,321
+2,592
+0.9% +$145K 0.48% 44
2015
Q1
$15.2M Buy
277,729
+7,022
+3% +$398K 0.44% 45
2014
Q4
$14.7M Buy
270,707
+2,213
+0.8% +$123K 0.45% 48
2014
Q3
$15.2M Sell
268,494
-5,355
-2% -$301K 0.52% 46
2014
Q2
$15.1M Sell
273,849
-2,289
-0.8% -$125K 0.51% 43
2014
Q1
$15M Buy
276,138
+1,958
+0.7% +$101K 0.54% 39
2013
Q4
$13.1M Buy
274,180
+2,270
+0.8% +$104K 0.49% 41
2013
Q3
$12.4M Sell
271,910
-4,463
-2% -$204K 0.5% 41
2013
Q2
$12.3M Buy
+276,373
New +$12.3M 0.5% 43

Other funds holding MRK

Securian Asset Management's MRK Position: Q2 2026 in Review

Securian Asset Management reduced its Merck (MRK) stake by 2.5% in Q2 2026, selling an estimated $199K and leaving 65,631 shares worth $8.37M. The position accounts for 0.3% of the portfolio, ranked #49.

Securian Asset Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.6M in Q2 2023. 1,153 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Securian Asset Management held 65,631 shares of Merck worth $8.37M as of Q2 2026.
  • Securian Asset Management sold 1,702 Merck shares in Q2 2026, an estimated $199K.
  • Merck made up 0.3% of Securian Asset Management's portfolio in Q2 2026, its #49 holding.
  • Securian Asset Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Securian Asset Management's Merck position peaked at $24.6M in Q2 2023.
  • 1,153 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.